PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it publishes.
http://ww2.peerview.com
Sara M. Tinsley, PhD, APRN, AOCN / Laura J. Zitella, MS, RN, ACNP-BC, AOCN - Meeting the Many Challenges of AML: Oncology Nurse Tactics in an Era of Novel Therapies
Go online to PeerView.com/TZV860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, oncology nurse experts discuss evidence on the safety and efficacy of novel therapeutics for the treatment of acute myeloid leukemia (AML) and, using a series of case scenarios, provide guidance on how to integrate innovative treatment options into the care of different AML populations. Upon completion of this activity, participants will be able to: Cite updated evidence about the efficacy and safety of newer cytotoxic, targeted, and epigenetic strategies for the management of AML, Manage safety considerations in patients with AML who are receiving novel cytotoxic or targeted therapeutics, Address psychosocial, longer-term care, dosing, and adherence considerations in patients with AML who are receiving novel therapeutics, Educate patients about the clinical benefits of novel therapies, relevant prognostic factors, and potential safety issues associated with newly approved treatments for AML.